FDA approves Eli Lillys Zepbound, a weight loss drug similar to Ozempic and Wegovy

FDA approves Eli Lillys Zepbound, a weight loss drug similar to Ozempic and Wegovy

The Food and Drug Administration on Wednesday has approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that in clinical trials has been shown to help people lose up to 52 pounds in 16 months. Related to Zep is the latest entrant in the field of powerful new… Continue Reading FDA approves Eli Lillys Zepbound, a weight loss drug similar to Ozempic and Wegovy

FDA investigating reports of hospitalizations after fake Ozempic

FDA investigating reports of hospitalizations after fake Ozempic

At least three Americans were reportedly hospitalized after using suspected counterfeit semaglutide medications, including Novo Nordisk’s diabetes drug Ozempic, according to records released by the Food and Drug Administration. Ozempic and Wegovy, another semaglutide drug from Novo Nordisk, have been in shortage for months amid booming sales for their use… Continue Reading FDA investigating reports of hospitalizations after fake Ozempic

Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs

Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs

Business By Shannon Thaler Published November 1, 2023, 12:10 p.m. ET Growing demand for Ozempic and Wegovy, made by Novo Nordisk, has fueled a rise in illegal sales of weight-loss drugs in Denmark, where the pharmaceutical company is based, the Danish Medicines Agency reported. The agency said in a statement… Continue Reading Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs

Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs

Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs

Growing demand for Ozempic and Wegovy, made by Novo Nordisk, has fueled a rise in illegal sales of weight-loss drugs in Denmark, where the pharmaceutical company is based, the Danish Medicines Agency reported. The agency said in a statement released Tuesday that authorities are aware of 26 websites illegally selling… Continue Reading Demand for Ozempic and Wegovy increases illegal sales of weight-loss drugs

Demand for Ozempic and Wegovy is reaching new heights. Here’s why it can go even higher. | The motley fool

Demand for Ozempic and Wegovy is reaching new heights.  Here's why it can go even higher.  |  The motley fool

Ozempic and Wegovy. These are the two drugs that are the focus of any income or press release coming fromNovo Nordisk(NVO -0.09%). The Danish company struck gold not only with a cutting-edge diabetes drug in Ozempic, but also with an impressive weight loss treatment in Wegovy. Both drugs actually help… Continue Reading Demand for Ozempic and Wegovy is reaching new heights. Here’s why it can go even higher. | The motley fool

Weight-loss drugs are safe if used correctly, West Palm Beach doctor says

Weight-loss drugs are safe if used correctly, West Palm Beach doctor says

WEST PALM BEACH, Florida. The Journal of the American Medical Association reports that some of the most popular medications available for weight loss, including Ozempic, Wegovy, and Saxenda, may be linked to an increased risk of serious stomach problems in some people. The research was published earlier this month and… Continue Reading Weight-loss drugs are safe if used correctly, West Palm Beach doctor says

1 Big risk facing Ozempic, Wegovy and other GLP-1 weight loss drugs | The motley fool

1 Big risk facing Ozempic, Wegovy and other GLP-1 weight loss drugs |  The motley fool

Weight loss medications have grown in popularity in recent years. People even use a drug like Ozempic, although it is only approved for diabetes, simply because it helps them lose weight. In the last three months of 2022 alone, more than 9 million prescriptions for weight loss drugs were dispensed… Continue Reading 1 Big risk facing Ozempic, Wegovy and other GLP-1 weight loss drugs | The motley fool

Novo Nordisk warns of online offers against fake Ozempic and Wegovy on the rise

Novo Nordisk warns of online offers against fake Ozempic and Wegovy on the rise

By Maggie Fick and Ludwig Burger (Reuters) – Novo Nordisk warned on Thursday of a rise in counterfeit versions of its weight-loss drug Wegovy and diabetes drug Ozempic offered online, as German authorities gave more details about complex European trades in a case of fake medicines. “Novo Nordisk has seen… Continue Reading Novo Nordisk warns of online offers against fake Ozempic and Wegovy on the rise

Woman sues Wegovy to get health insurance to cover her

Woman sues Wegovy to get health insurance to cover her

Image of Michael Siluk/UCG via Getty / Futurism Amid a months-long shortage of semaglutide diabetes and weight loss medications, a woman is suing her insurer for failing to cover the drugs. As theNew York Times According to reports, Washington state nurse Jeannette Simonton was told her insurer was completely banning… Continue Reading Woman sues Wegovy to get health insurance to cover her